MedTrace Logo

Percutaneous Recanalization in Ischemic Stroke Management (PRIISM): A Feasibility Clinical Study

NCT00810095 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2012-07-26

Study results available
· View outcomes & findings →

Summary

The primary study objective is to assess the feasibility of using the MindFrame System to safely and effectively restore blood flow in a thrombotic neurovascular occlusion in patients experiencing an ischemic stroke.

Conditions

Interventions

DEVICE

MindFrame System

Thrombectomy Catheter designed to rapidly restore blood flow in patients experiencing an ischemic stroke

Sponsors & Collaborators

  • MindFrame, Inc.

    lead INDUSTRY

Principal Investigators

  • Martin Bendszus, MD, PhD · Heidelberg University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2011-04-30
Completion
2011-04-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00810095 on ClinicalTrials.gov